Gene: SANBR
Official Full Name: SANT and BTB domain regulator of CSRprovided by HGNC
Gene Summary: Predicted to enable identical protein binding activity. Predicted to be involved in isotype switching. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14364 | SANBR Knockout cell line (HeLa) | Human | SANBR | 1:3~1:6 | Negative | Online Inquiry |
KO14365 | SANBR Knockout cell line (HCT 116) | Human | SANBR | 1:2~1:4 | Negative | Online Inquiry |
KO14366 | SANBR Knockout cell line (HEK293) | Human | SANBR | 1:3~1:6 | Negative | Online Inquiry |
KO14367 | SANBR Knockout cell line (A549) | Human | SANBR | 1:3~1:4 | Negative | Online Inquiry |
SANBR Gene Knockout Cell Lines are meticulously engineered cellular models designed to facilitate the study of gene function and the subsequent effects of gene disruption in a controlled environment. Produced using advanced CRISPR-Cas9 genome editing technology, these cell lines provide a valuable resource for researchers investigating the roles of specific genes in cellular processes, disease mechanisms, and therapeutic responses.
The key function of SANBR Gene Knockout Cell Lines lies in their ability to create precise gene knockouts, allowing for the observation of resultant phenotypic changes. This is achieved by disrupting the target gene sequence, leading to a loss of function that can reveal insights into cellular pathways and molecular interactions. Utilizing these cell lines, researchers can perform functional assays, elucidate gene interactions, and evaluate the potential of targeted therapies, making SANBR particularly beneficial for applications in cancer research, regenerative medicine, and drug discovery.
The scientific importance of these cell lines is underscored by their widespread applicability in both research and clinical contexts. They serve as essential tools for investigating genetic diseases, understanding tumor biology, and developing novel therapeutic interventions. By offering a reliable model system, SANBR Gene Knockout Cell Lines empower researchers to uncover detailed mechanistic insights that drive innovation in personalized medicine and treatment strategies.
Compared to traditional cell line models, SANBR Gene Knockout Cell Lines are distinguished by their precision and specificity. Unlike older technologies that may introduce random mutations or miss critical regulatory elements, the CRISPR-Cas9 system employed ensures targeted and reproducible edits. As a result, these cell lines exhibit greater consistency in experimental outcomes, reducing variability and enabling more robust data collection.
For researchers and clinicians seeking to drive advancements in genetic research and therapy development, the SANBR Gene Knockout Cell Lines are an indispensable resource. Their capacity to provide clear insights into gene function positions them as critical instruments for developing next-generation treatments in a variety of diseases. Leveraging our deep expertise in cellular and molecular biology, our company is committed to delivering high-quality, innovative tools that empower the scientific community in their quest for knowledge and breakthrough therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.